Rezultati - Ibrahim Turkoz

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Does Half-Life Matter After Antipsychotic Discontinuation?

    Does Half-Life Matter After Antipsychotic Discontinuation? od Peter J. Weiden, Edward Kim, Jason Bermak, Ibrahim Turkoz, Srihari Gopal, Joris Berwaerts

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia

    Three-Year Outcomes of 6-Month Paliperidone Palmitate in Adults With Schizophrenia od Christoph U. Correll, Karen L. Johnston, Ibrahim Turkoz, J. Gray, Liping Sun, Monica Doring, Martha Sajatovic

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression

    Placebo-Controlled Study of Relapse Prevention With Risperidone Augmentation in Older Patients with Resistant Depression od George S. Alexopoulos, Carla M. Canuso, Georges M. Gharabawi, Cynthia A. Bossie, Andrew Greenspan, Ibrahim Turkoz, Charles F. Reynolds

    Izdano 2007
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse frequently

    A randomized, double‐blind, placebo‐controlled study of maintenance treatment with adjunctive risperidone long‐acting therapy in patients with bipolar I disorder who relapse freque... od Wayne Macfadden, Larry Alphs, J. Thomas Haskins, Norris Turner, Ibrahim Turkoz, Cynthia A. Bossie, Mary J. Kujawa, Ramy Mahmoud

    Izdano 2009
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression

    Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression od Ibrahim Turkoz, Larry Alphs, Jaskaran Singh, Carol Jamieson, Ella Daly, M. Shawi, John J. Sheehan, Madhukar H. Trivedi, A. John Rush

    Izdano 2020
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffective Disorder

    Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffe... od Dong‐Jing Fu, Ibrahim Turkoz, Richard Bruce Simonson, David P. Walling, Nina R. Schooler, Jean‐Pierre Lindenmayer, Carla M. Canuso, Larry Alphs

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior

    Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior od Carla M. Canuso, Dawn F. Ionescu, Xiang Li, Xin Qiu, Rosanne Lane, Ibrahim Turkoz, Abigail I. Nash, Tricia J. Lopena, Dong‐Jing Fu

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study

    Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study od Meredith Castro, Samuel T. Wilkinson, Rayan K. Al Jurdi, Mary Pat Petrillo, Naim Zaki, Stephane Borentain, Dong Jing Fu, Ibrahim Turkoz, Sun Li-ping, Brianne Brown, Patricia Cabrera

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation

    Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation od Mark Hyman Rapaport, Georges M. Gharabawi, Carla M. Canuso, Ramy Mahmoud, Martin B. Keller, Cynthia A. Bossie, Ibrahim Turkoz, Robert Lasser, Amy Loescher, Philippe Bouhours, Fiona Dunbar, Charles B. Nemeroff

    Izdano 2006
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: